Answers are grounded in this paper and cite their sources.
by 68%±0.43. In conclusion, a compound could play a role as a telomerase activator in one cell line while it could play another role as a telomerase inhibitor in another cell line so introducing compounds as a telomerase inhibitor (anticancer) or as a telomerase activator (anti-aging) should be done with discreet.
No takes yet. Share an insight, caveat, or question.
Akbarizare et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: